SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-016250
Filing Date
2022-08-10
Accepted
2022-08-10 07:05:30
Documents
14
Period of Report
2022-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-20220810.htm   iXBRL 8-K 60884
2 EX-99.1 acet-ex99_1.htm EX-99.1 221120
  Complete submission text file 0000950170-22-016250.txt   441110

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20220810_pre.xml EX-101.PRE 12155
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20220810.xsd EX-101.SCH 2907
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acet-20220810_def.xml EX-101.DEF 12841
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20220810_lab.xml EX-101.LAB 16059
8 EXTRACTED XBRL INSTANCE DOCUMENT acet-20220810_htm.xml XML 5990
Mailing Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 221150374
SIC: 2834 Pharmaceutical Preparations